When was Longevity Vision Fund founded?

Longevity Vision Fund was founded in 2019.

Where is Longevity Vision Fund headquartered?

Longevity Vision Fund is headquartered in New York, NY.

What is Longevity Vision Fund's total asset value?

Longevity Vision Fund has around in total assets under management.

How many investments has Longevity Vision Fund made?

Longevity Vision Fund has made 21 investments.

What has Longevity Vision Fund invested in?

Longevity Vision Fund has made numerous investments in companies like Sail Biomedicines , Biolinq , and Senda Biosciences within the Biotechnology and Monitoring Equipment industries.

What has Longevity Vision Fund invested in recently?

Longevity Vision Fund's latest investment was on 19-Oct-2023 in Sail Biomedicines , a company within the Biotechnology industry.

Longevity Vision Fund investment portfolio

Longevity Vision Fund Overview

Investor Type

Venture Capital

Status

Active

Professionals

2

Investments

21

Portfolio

13

Exits

3

Longevity Vision Fund General Information

Company Description

Founded in 2019, Longevity Vision Fund is a venture capital firm based in New York, New York. The firm seeks to invest in preventive medicine and early detection, medical technologies and devices, artificial intelligence in healthcare, longevity therapies and regenerative medicine, and healthcare infrastructure sectors. This firm is a Registered Investment Adviser (RIA).

Business Details

Website

longevity.vision

Year Founded

2019

Investor Status

Actively Seeking New Investments

Primary Investor Type

Venture Capital

Corporate Office

57 West 57th street
4th Floor
New York, NY 10019
United States



Longevity Vision Fund Investments & Acquisitions (21)

Company Name	Deal Date	Deal Type	Industry	Company Stage
Sail Biomedicines	19-Oct-2023	Merger of Equals	Biotechnology	Generating Revenue
Biolinq	17-Oct-2022		Monitoring Equipment	Clinical Trials - Phase 2
Senda Biosciences	16-Aug-2022		Biotechnology	Generating Revenue
Tessera Therapeutics	20-Apr-2022		Biotechnology	Generating Revenue
Cambrian Bio	15-Oct-2021		Drug Discovery	Clinical Trials - Phase 2
Laronde	28-Jul-2021		Drug Discovery	Generating Revenue
Senda Biosciences	10-Jun-2021		Biotechnology	Generating Revenue
Valo	11-Mar-2021		Discovery Tools (Healthcare)	Generating Revenue
Tessera Therapeutics	12-Jan-2021	Early Stage VC	Biotechnology	Generating Revenue
LyGenesis	30-Dec-2020	Early Stage VC	Biotechnology	Clinical Trials - Phase 2

You’re viewing 10 of 21 investments and acquisitions. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Longevity Vision Fund Exits (3)

Company Name	Exit Date	Exit Type
Deep Longevity	14-Dec-2020	Merger/Acquisition
4D Molecular Therapeutics	11-Dec-2020
Sigilon Therapeutics	04-Dec-2020

To view Longevity Vision Fund’s complete exits history, request access »

Longevity Vision Fund Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.